Terms: = Adult Hodgkin lymphoma AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
107 results:
1. Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P; Bomken S; Ling R; Lazareva A; Gupte G; Amrolia P; Andrés M; Diez-Sebastián J; Taj MM
Pediatr Blood Cancer; 2024 Aug; 71(8):e31053. PubMed ID: 38757407
[TBL] [Abstract] [Full Text] [Related]
2. B-cell lymphoma research in Malaysia - A narrative review.
Lim KG; Sumera A; Venkateswaran SP; Burud IAS; Albazah NIJ
Malays J Pathol; 2024 Apr; 46(1):11-20. PubMed ID: 38682841
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
[No Abstract] [Full Text] [Related]
4. hodgkin lymphoma: A disease shaped by the tumor micro- and macroenvironment.
Masel R; Roche ME; Martinez-Outschoorn U
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
[TBL] [Abstract] [Full Text] [Related]
5. BET inhibitors induce NF-κB and E2F downregulation in hodgkin and Reed-Sternberg cells.
Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
[TBL] [Abstract] [Full Text] [Related]
6. myc rearrangement and concurrent high protein expression of C-myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma.
Wang X; He J; He H; Shuai Y; Wang L; Li Y; Huang Y; Yu K; Zhao M; Xie T; Li D
Ann Diagn Pathol; 2023 Oct; 66():152165. PubMed ID: 37348414
[TBL] [Abstract] [Full Text] [Related]
7. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
[TBL] [Abstract] [Full Text] [Related]
8. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
[TBL] [Abstract] [Full Text] [Related]
9. Richter transformation in Chronic Lymphocytic Leukemia.
Innocenti I; Benintende G; Tomasso A; Fresa A; Autore F; Larocca LM; Laurenti L
Hematol Oncol; 2023 Aug; 41(3):293-300. PubMed ID: 36433773
[TBL] [Abstract] [Full Text] [Related]
10. Two cases of follicular lymphoma with myc gene abnormalities that presented with bone marrow necrosis.
Miyazawa Y; Takei H; Kobayashi N; Akashi N; Sairenji Y; Sugisaki M; Naito C; Ishikawa T; Shimizu H; Ishizaki T; Yokohama A; Tsukamoto N; Yoshida Y; Matsumura N; Takayama Y; Handa H
J Clin Exp Hematop; 2022 Dec; 62(4):208-216. PubMed ID: 36261333
[TBL] [Abstract] [Full Text] [Related]
11. First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy.
Diamond JR; Boni V; Lim E; Nowakowski G; Cordoba R; Morillo D; Valencia R; Genvresse I; Merz C; Boix O; Frigault MM; Greer JM; Hamdy AM; Huang X; Izumi R; Wong H; Moreno V
Clin Cancer Res; 2022 Apr; 28(7):1285-1293. PubMed ID: 35046056
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial.
Chiappella A; Diop F; Agostinelli C; Novo M; Nassi L; Evangelista A; Ciccone G; Di Rocco A; Martelli M; Melle F; Moia R; Motta G; Righi S; Santambrogio E; Tucci A; Balzarotti M; Ladetto M; Pileri SA; Gaidano G; Vitolo U;
Br J Haematol; 2022 Mar; 196(5):1184-1193. PubMed ID: 34951009
[TBL] [Abstract] [Full Text] [Related]
13. Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
Landsburg DJ; Barta SK; Ramchandren R; Batlevi C; Iyer S; Kelly K; Micallef IN; Smith SM; Stevens DA; Alvarez M; Califano A; Shen Y; Bosker G; Parker J; Soikes R; Martinez E; von Roemeling R; Martell RE; Oki Y
Br J Haematol; 2021 Oct; 195(2):201-209. PubMed ID: 34341990
[TBL] [Abstract] [Full Text] [Related]
14. Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.
Ren S; Cai Y; Hu S; Liu J; Zhao Y; Ding M; Chen X; Zhan L; Zhou X; Wang X
Biochem Pharmacol; 2021 Jun; 188():114576. PubMed ID: 33930347
[TBL] [Abstract] [Full Text] [Related]
15. Revisiting Richter transformation in the era of novel CLL agents.
Petrackova A; Turcsanyi P; Papajik T; Kriegova E
Blood Rev; 2021 Sep; 49():100824. PubMed ID: 33775465
[TBL] [Abstract] [Full Text] [Related]
16. Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma.
Youssef Y; Karkhanis V; Chan WK; Jeney F; Canella A; Zhang X; Sloan S; Prouty A; Helmig-Mason J; Tsyba L; Hanel W; Zheng X; Zhang P; Chung JH; Lucas DM; Kauffman Z; Larkin K; Strohecker AM; Ozer HG; Lapalombella R; Zhou H; Xu-Monette ZY; Young KH; Han R; Nurmemmedov E; Nuovo G; Maddocks K; Byrd JC; Baiocchi RA; Alinari L
Haematologica; 2021 Nov; 106(11):2927-2939. PubMed ID: 33054136
[TBL] [Abstract] [Full Text] [Related]
17. Burkitt lymphoma - Subtypes, Pathogenesis, and treatment Strategies.
Noy A
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S37-S38. PubMed ID: 32862862
[TBL] [Abstract] [Full Text] [Related]
18. High-grade B-cell lymphoma with myc and BCL6 rearrangements presenting as a cervical mass.
Costa PA; Needelman BS; Tjendra Y; Hoffman JE
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843454
[TBL] [Abstract] [Full Text] [Related]
19. Etoposide-mediated interleukin-8 secretion from bone marrow stromal cells induces hematopoietic stem cell mobilization.
Kang KW; Lee SJ; Kim JH; Lee BH; Kim SJ; Park Y; Kim BS
BMC Cancer; 2020 Jul; 20(1):619. PubMed ID: 32615949
[TBL] [Abstract] [Full Text] [Related]
20. Non-diffuse large B-cell lymphoma transformation from follicular lymphoma: a single-institution study of 19 cases.
Maeshima AM; Taniguchi H; Ida H; Hosoba R; Fujino T; Saito Y; Yuda S; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2020 Aug; 102():33-43. PubMed ID: 32540222
[TBL] [Abstract] [Full Text] [Related]
[Next]
